Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Impact of Female-To-Male Allogeneic Hematopoietic Cell Transplantation on Survival Outcomes Varies by Recipient Age.

Transplantation and cellular therapy·2026

Same author

Impact of Glycine-Serine Linker on Target Antigen Binding and Subsequent CD37CAR-T Performance.

International journal of molecular sciences·2026

Same author

[Biomarkers for enhancing efficacy of CAR-T cell therapy].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Same author

BATF3 regulates differentiation of CD8<sup>+</sup> T lymphocytes and memory differentiation program.

Life science alliance·2026

Same author

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

Journal for immunotherapy of cancer·2026

Same author

Percentage of CD56<sup>+</sup> monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Annals of hematology·2026

Search research articles

Related Experiment Video

Updated: Jul 12, 2025

Scalable, Flexible, and Cost-Effective Seedling Grafting

Scalable, Flexible, and Cost-Effective Seedling Grafting

Published on: January 6, 2023

[Selection strategy for graft source in 2023].

Seitaro Terakura¹

¹Department of Hematology and Oncology, Nagoya University Hospital.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology

|October 29, 2023

Summary

This summary is machine-generated.

Allogeneic stem cell transplants now utilize diverse graft sources, including haplo-mismatched donors. Severe graft-versus-host disease, while a complication, correlates with fewer leukemia relapses, aiding graft selection in allogeneic hematopoietic stem cell transplantation.

Keywords:

Allogeneic hematopoietic stem cell transplantation Graft selection Post-transplant cyclophosphamide Strategy

More Related Videos

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Published on: November 19, 2019

Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency

Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency

Published on: January 15, 2017

Related Experiment Videos

Last Updated: Jul 12, 2025

Scalable, Flexible, and Cost-Effective Seedling Grafting

Scalable, Flexible, and Cost-Effective Seedling Grafting

Published on: January 6, 2023

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Published on: November 19, 2019

Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency

Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency

Published on: January 15, 2017

Area of Science:

Hematology
Immunology
Oncology

Context:

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has evolved to include related, unrelated, and umbilical cord blood grafts.
HLA-matched and HLA-haplo-mismatched donor options are now widely available for patients.
Post-transplant cyclophosphamide has enabled safe allo-HSCT from HLA-haplo-mismatched donors.

Purpose:

To compare transplant outcomes from various donor sources for allo-HSCT.
To guide graft selection strategies in allo-HSCT.
To evaluate the role of post-transplant cyclophosphamide in HLA-haplo-mismatched allo-HSCT.

Summary:

Graft selection in allo-HSCT involves balancing graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects.
Severe GVHD, though a complication, is associated with reduced relapse rates, potentially offsetting negative impacts.
Data comparing outcomes from different donor sources, including HLA-haplo-mismatched donors with post-transplant cyclophosphamide, are presented.

Impact:

Provides evidence-based guidance for optimizing graft selection in allo-HSCT.
Clarifies the complex relationship between GVHD and GVL effects.
Informs clinical practice regarding the use of HLA-haplo-mismatched donors and post-transplant cyclophosphamide.